(Q51765787)

11 April 2018

title

Concomitant weekly cisplatin and altered fractionation radiotherapy in locally advanced head and neck cancer. (English)

1 reference

11 April 2018

Adaptive radiation therapy

main subject

0 references

1 reference

Heather E Newlin

1

1 reference

11 April 2018

Robert J Amdur

2

1 reference

11 April 2018

Charles E Riggs

3

1 reference

11 April 2018

Christopher G Morris

4

1 reference

11 April 2018

Jessica M Kirwan

5

1 reference

11 April 2018

William M Mendenhall

6

1 reference

11 April 2018

language of work or name

English

0 references

publication date

1 October 2010

1 reference

11 April 2018

published in

Cancer

1 reference

11 April 2018

volume

116

1 reference

11 April 2018

issue

19

1 reference

11 April 2018

page(s)

4533-4540

1 reference

11 April 2018

Meta-Analyses of Chemotherapy in Head and Neck Cancer (MACH-NC): an update.

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25189

7 January 2021

A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25189

7 January 2021

Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25189

7 January 2021

A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25189

7 January 2021

Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25189

7 January 2021

Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25189

7 January 2021

An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25189

7 January 2021

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25189

7 January 2021

Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long-term results of the Radiation Therapy Oncology Group study 81-17

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25189

7 January 2021

Cisplatin and radiotherapy in the management of locally advanced head and neck cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25189

7 January 2021

Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25189

7 January 2021

Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25189

7 January 2021

Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25189

7 January 2021

Definitive radiotherapy for head-and-neck cancer with radiographically positive retropharyngeal nodes: incomplete radiographic response does not necessarily indicate failure

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25189

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25189

7 January 2021

Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of the head and neck: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25189

7 January 2021

Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology group (RTOG 99-14).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25189

7 January 2021

Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: radiation therapy oncology group phase II trial 99-14

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25189

7 January 2021

Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25189

7 January 2021

Identifiers

DOI

10.1002/CNCR.25189

1 reference

11 April 2018

1 reference

11 April 2018